Brief: Xbiotech Commences Tender Offer To Purchase Up To $420,000,000 Of Its Shares
Jan 14 (Reuters) - XBiotech Inc XBIT.O :
* XBIOTECH COMMENCES TENDER OFFER TO PURCHASE UP TO
$420,000,000
OF ITS SHARES
* XBIOTECH INC - OFFER IS SCHEDULED TO EXPIRE AT 5:00 P.M.,
NEW
YORK CITY TIME, ON FEB 12, 2020, UNLESS OFFER IS EXTENDED
Source text for Eikon: ID:nGNE2WWNgJ
Further company coverage: XBIT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XBiotech
See all newsBrief: XBiotech Announces Positive Final Efficacy Results From Phase II Taskin Trial
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: Xbiotech Launches Phase Ii Clinical Trial Evaluating Vilamakitug For The Treatment Of Active Axial Spondyloarthritis
Brief: XBiotech Inc - John Simard To Retire As CEO Of XBiotech - SEC Filing
Brief: Xbiotech Announces Enrollment Completion Of Phase I Clinical Trial For Hutrukin, A Novel Candidate Therapy For Stroke